腹膜透析人群中腹膜炎与心血管死亡随时间的关系:澳大利亚与新西兰透析与移植登记研究
该研究纳入澳大利亚2003年10月至2019年12月开始腹膜透析的9699例成人患者,采用Cox比例风险分析和竞争风险分析评估腹膜炎与心血管死亡的关联,并比较不同时代腹膜炎发生率与心血管死亡的关系。结果显示腹膜炎与心血管死亡风险升高独立相关,且呈发作次数依赖性,2012至2019年开始透析者心血管死亡风险低于2003至2011年开始者。
要点
- 腹膜炎与心血管死亡风险升高独立相关(SHR 1.53,95%CI 1.39-1.69,P<0.001)。
- 腹膜炎发作次数越多,心血管死亡风险越高:1次SHR 1.41,≥2次SHR 1.69。
- 2012至2019年开始腹膜透析者心血管死亡风险低于2003至2011年开始者(SHR 0.60)。
核心结论
- 腹膜炎与心血管死亡风险升高独立相关,且关联呈发作次数依赖性;预防和充分治疗腹膜透析腹膜炎可能改善腹膜透析患者的心血管结局。
研究设计与样本
- 研究为基于澳大利亚与新西兰透析与移植(ANZDATA)登记的前瞻性队列分析,纳入2003年10月至2019年12月在澳大利亚开始腹膜透析的9699例成人(≥18岁)患者。
主要发现
- 总体腹膜炎发生率为每患者年0.37次,研究期间下降4.7%(95%CI 3.6-5.8%)。
- 腹膜炎与心血管死亡风险升高相关(SHR 1.53,95%CI 1.39-1.69,P<0.001)。
- 随腹膜炎发作次数增加心血管死亡风险升高:1次发作SHR 1.41(95%CI 1.24-1.61),≥2次发作SHR 1.69(95%CI 1.47-1.93),P<0.001。
- 与2003至2011年开始腹膜透析者相比,2012至2019年开始者心血管死亡风险更低(SHR 0.60,95%CI 0.50-0.72,P<0.001)。
- 敏感性分析结果一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Though peritonitis is associated with increased mortality in patients receiving peritoneal dialysis (PD), its association with cardiovascular mortality remains uncertain. METHODS: The study participants included adult patients (≥18 years old) commencing PD in Australia (from October 2003 to December 2019) using the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry. Association between peritonitis and cardiovascular mortality was evaluated using Cox proportional hazards analysis and competing risks analysis. Associations between peritonitis rates between different eras and cardiovascular mortality were also compared using Jointpoint regression model to determine the time point when a significant change in peritonitis trend occurred to define the era for cardiovascular mortality. Subgroup analysis dividing the groups into 0, 1 and ≥2 episodes of peritonitis and sensitivity analysis censoring at 90 days post-transfer to hemodialysis (HD) were performed. RESULTS: The study included 9699 incident PD patients. The overall peritonitis rate was 0.37 episodes per patient-year and declined by 4.7% (95% confidence interval [CI] 3.6-5.8%) during the study period. Peritonitis was associated with increased cardiovascular mortality risk (subdistribution hazard ratio [SHR] 1.53, 95% CI 1.39-1.69, P < 0.001) with increasing peritonitis episodes associated with higher risk (1 episode of peritonitis SHR 1.41, 95%CI 1.24-1.61; ≥2 episodes of peritonitis SHR 1.69, 95% CI 1.47-1.93, P < 0.001). Patients who commenced PD between 2012 and 2019 had a lower risk of cardiovascular mortality (SHR 0.60, 95% CI 0.50-0.72, P < 0.001), compared to patients who commenced between 2003 and 2011. Results were consistent in the sensitivity analysis. CONCLUSION: Peritonitis is independently associated with an increased risk of cardiovascular mortality, and the association is episode-dependent. Prevention and adequate treatment of PD peritonitis may improve cardiovascular outcomes among patients receiving PD.
引用
- Cheikh Hassan HI, Murali K, Lonergan M, et al. Association of Peritonitis With Cardiovascular Mortality Over Time in the Peritoneal Dialysis Population: An Australia and New Zealand Dialysis and Transplant Registry Study. Kidney Int Rep. 2022. PMID: 36531876. doi:10.1016/j.ekir.2022.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。